Related Experiment Videos
Impact of Armed Conflict on Cancer Care in Sudan: Challenges and Strategic Responses
Yasar Ahmed1,2, Nabeeha Karadawi3, Mutasim Abubaker4
1Medical Oncology Department, St Vincent's University Hospital, Dublin, Ireland.
Abstract:
The armed conflict that erupted in Sudan on April 15, 2023, has precipitated a catastrophic collapse of the nation's health care system, with oncology services bearing particularly devastating consequences. Once a regional leader in cancer care, Sudan's health care infrastructure, including its flagship Khartoum Oncology Hospital and numerous comprehensive cancer centers, has been rendered nearly nonfunctional. This crisis has left thousands of patients with cancer without access to essential treatments, exacerbating an already dire public health situation. The conflict has not only disrupted medical supply chains but also displaced health care personnel, further crippling the ability to deliver life-saving care. This manuscript provides a critical analysis of the impact of the conflict on cancer care in Sudan, focusing on the redistribution of patients to peripheral oncology centers and the strain on these facilities. Although existing literature has highlighted the collapse of health care infrastructure, this study offers new quantitative data on the surge in patient numbers at centers such as the East Oncology Centre and the White Nile Cancer Centre, alongside the critical shortages of medical supplies. It also underscores the equity concerns arising from the lack of global attention to Sudan's cancer care crisis compared with other conflict zones. By shedding light on these issues, this study aims to galvanize international action to support Sudanese patients with cancer and rebuild its health care system.
Related Concept Videos
Cancer Survival Analysis
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Treatment Resistant Cancers